
We report on a Dutch family in which 4 members in 2 generations have intermediate repeat lengths (53 and 54) for Machado-Joseph Disease/Spinocerebellar Ataxia (MJD/SCA3). All but the youngest have a restless legs syndrome with fasciculations and a sensorimotor axonal polyneuropathy. Central neurological abnormalities are only present in 2. This family shows that intermediate repeat lengths can be pathogenic and may predispose for restless legs and peripheral nerve disorder.
Contains fulltext : 166942.pdf (Publisher’s version ) (Open Access)
Male, Nuclear Proteins, Pathofysiologie van Hersenen en Gedrag, Nerve Tissue Proteins, Machado-Joseph Disease, Pathophysiology of Brain and Behaviour, Middle Aged, Pedigree, Repressor Proteins, Phenotype, Restless Legs Syndrome, Humans, Female, Ataxin-3, Hereditary Sensory and Motor Neuropathy, Trinucleotide Repeat Expansion, Aged, Netherlands
Male, Nuclear Proteins, Pathofysiologie van Hersenen en Gedrag, Nerve Tissue Proteins, Machado-Joseph Disease, Pathophysiology of Brain and Behaviour, Middle Aged, Pedigree, Repressor Proteins, Phenotype, Restless Legs Syndrome, Humans, Female, Ataxin-3, Hereditary Sensory and Motor Neuropathy, Trinucleotide Repeat Expansion, Aged, Netherlands
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 85 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
